Nomura Asset Management CO LTD Harmony Biosciences Holdings, Inc. Transaction History

Nomura Asset Management CO LTD

  • $31.8 Billion
  • Q3 2024

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$30.5 - $37.4 $0 - $0
0 New
0 $0
Q1 2023

May 11, 2023
BUY
$30.8 - $53.92 $0 - $0
0 New
0 $0
Q4 2022

Feb 14, 2023
BUY
$45.4 - $60.91 $0 - $0
0 New
0 $0
Q3 2022

Nov 14, 2022
BUY
$42.06 - $55.45 $0 - $0
0 New
0 $0
Q3 2022

Nov 10, 2022
BUY
$42.06 - $55.45 $0 - $0
0 New
0 $0
Q3 2022

Nov 10, 2022
BUY
$42.06 - $55.45 $0 - $0
0 New
0 $0
Q2 2022

Aug 12, 2022
BUY
$33.54 - $52.15 $0 - $0
0 New
0 $0
Q1 2022

May 13, 2022
BUY
$33.14 - $51.13 $0 - $0
0 New
0 $0
Q4 2021

Feb 01, 2022
BUY
$34.09 - $43.91 $0 - $0
0 New
0 $0

Others Institutions Holding HRMY

# of Institutions
242
Shares Held
45.1M
Call Options Held
108K
Put Options Held
49.2K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email